<p>BALB/c female mice were immunized intranasally with PBS alone, DOTAP/DC-chol liposomes (0.4 μmol/mouse) alone, OVA (5 μg/mouse) alone, or OVA (5 μg/mouse) plus DOTAP/DC-chol liposomes (0.4 μmol/mouse) once weekly (days 0, 7, 14, 21, and 28). Serum was collected every week immediately prior to immunization (days 0, 7, 14, 21, 28, and 35). Anti-OVA IgG, IgG1, and IgG2a levels in serum were determined by ELISA assay. The data are obtained from at least three independent experiments and are expressed as the mean ± the standard error. Significance was assessed with the Kruskal–Wallis with Dunn’s post–hoc test: *<i>p</i><0.05, **<i>p</i><0.0001.</p
<p>Each mouse group was nasally immunized three times at weekly intervals with OVA plus Ad-FL. (A) S...
<p>Mice were intranasally immunized with OVA plus 500 µg of PMB 3 times at weekly intervals. One gro...
<p>OVA-specific IgG1 levels were measured in sera of sensitized wild type mice that were either chal...
<p>BALB/c female mice were immunized intranasally with PBS, OVA (5 μg/mouse) alone, or OVA (5 μg/mou...
<p>BALB/c female mice were immunized intranasally with various doses of OVA plus DOTAP/DC-chol lipos...
<p>C3H/HeN and C3H/Hen mice were intranasally immunized with OVA plus 500 µg of PMB 3 times at weekl...
<p>Mice were intranasally immunized with ovalbumin (OVA) plus 0, 2.5, 5, 10, 25, 50, 100, 250, or 50...
<p>BALB/c female mice were immunized intranasally with PBS, OVA (5 μg/mouse) alone, OVA (5 μg/mouse)...
<p>Serum samples of WT and <i>mev/+</i> mice were collected within 2 hrs after challenge and OVA all...
<p>(A) Vα19Tg and non-Tg mice (C57BL/6 genetic background) were immunized with OVA (at week 0 and 2)...
<p>Mice were administered PBS (control), soluble Ova, or 20 nm NP-Ova p.o. at day 0, 3, 6 and 8, the...
<p>Mice were OVA-sensitized as described in <a href="http://www.plosone.org/article/info:doi/10.1371...
<p>Mice were immunized vaginally with 20 nm NP-Ova or PBS (control), then s.c. boosted with 300 µg O...
<p>WT mice were immunized with LPS+OVA, OVA-liposomes, or LPS-OVA-liposomes (10 µg each per mouse, i...
C57BL/6 mice (n = 10/group) were immunized i.m. with ovalbumin (20 μg) with or without adjuvant on d...
<p>Each mouse group was nasally immunized three times at weekly intervals with OVA plus Ad-FL. (A) S...
<p>Mice were intranasally immunized with OVA plus 500 µg of PMB 3 times at weekly intervals. One gro...
<p>OVA-specific IgG1 levels were measured in sera of sensitized wild type mice that were either chal...
<p>BALB/c female mice were immunized intranasally with PBS, OVA (5 μg/mouse) alone, or OVA (5 μg/mou...
<p>BALB/c female mice were immunized intranasally with various doses of OVA plus DOTAP/DC-chol lipos...
<p>C3H/HeN and C3H/Hen mice were intranasally immunized with OVA plus 500 µg of PMB 3 times at weekl...
<p>Mice were intranasally immunized with ovalbumin (OVA) plus 0, 2.5, 5, 10, 25, 50, 100, 250, or 50...
<p>BALB/c female mice were immunized intranasally with PBS, OVA (5 μg/mouse) alone, OVA (5 μg/mouse)...
<p>Serum samples of WT and <i>mev/+</i> mice were collected within 2 hrs after challenge and OVA all...
<p>(A) Vα19Tg and non-Tg mice (C57BL/6 genetic background) were immunized with OVA (at week 0 and 2)...
<p>Mice were administered PBS (control), soluble Ova, or 20 nm NP-Ova p.o. at day 0, 3, 6 and 8, the...
<p>Mice were OVA-sensitized as described in <a href="http://www.plosone.org/article/info:doi/10.1371...
<p>Mice were immunized vaginally with 20 nm NP-Ova or PBS (control), then s.c. boosted with 300 µg O...
<p>WT mice were immunized with LPS+OVA, OVA-liposomes, or LPS-OVA-liposomes (10 µg each per mouse, i...
C57BL/6 mice (n = 10/group) were immunized i.m. with ovalbumin (20 μg) with or without adjuvant on d...
<p>Each mouse group was nasally immunized three times at weekly intervals with OVA plus Ad-FL. (A) S...
<p>Mice were intranasally immunized with OVA plus 500 µg of PMB 3 times at weekly intervals. One gro...
<p>OVA-specific IgG1 levels were measured in sera of sensitized wild type mice that were either chal...